Coloplast A/S (OTCMKTS:CLPBY) Lowered to "Strong Sell" Rating by The Goldman Sachs Group

Key Points

• Goldman Sachs downgraded Coloplast A/S from a "hold" to a "strong sell", while MarketBeat shows an average analyst rating of "Reduce" (three Holds, one Sell).
• Coloplast reported quarterly EPS of $0.10 (beating the $0.09 estimate) but revenue missed slightly at $1.11B versus $1.12B expected; the stock opened at $6.59 (down 2.1%), with a 12‑month range of $6.51–$11.44 and a market cap around $14.85B.

Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) was downgraded by analysts at The Goldman Sachs Group from a "hold" rating to a "strong sell" rating in a report issued on Tuesday,Zacks.com reports.

Separately, Sanford C. Bernstein upgraded Coloplast A/S to a "hold" rating in a research note on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Coloplast A/S currently has an average rating of "Reduce".

Coloplast A/S Trading Down 2.1%

OTCMKTS:CLPBY opened at $6.59 on Tuesday. Coloplast A/S has a twelve month low of $6.51 and a twelve month high of $11.44. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50. The business has a 50 day moving average price of $7.30 and a two-hundred day moving average price of $8.34. The company has a market cap of $14.85 billion, a P/E ratio of 24.41, a price-to-earnings-growth ratio of 0.72 and a beta of 0.50.

Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) last announced its quarterly earnings data on Friday, February 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%.The company had revenue of $1.11 billion for the quarter, compared to analysts' expectations of $1.12 billion. As a group, analysts expect that Coloplast A/S will post 0.31 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast's offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.